Nocturia

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
N Neurology/Psychiatry (ATC N) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase IV: 2

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

2 trials
  • Idorsia Pharmaceuticals Ltd. Academic
    DARIDOREXANT
    2022-501246-30-00 2 countries 2023 n=35
    Ended
  • Idorsia Pharmaceuticals Ltd. Academic
    DARIDOREXANT
    2022-501246-30-00 2 countries 2023 n=35
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Idorsia Pharmaceuticals Ltd. Academic 2 Phase IV 0
New trials by year
2023
2
← All indication landscapes